Status:
COMPLETED
Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Procter and Gamble
Ste. Croix Hospital, Leogane, Haiti
Conditions:
Lymphedema
Cellulitis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Introduction. Lymphatic filariasis is a devastating mosquito-transmitted parasitic disease that causes lymphedema or elephantiasis of the leg in 15 million persons, the majority of whom are women. In ...
Eligibility Criteria
Inclusion
- Patients eligible for participation include those who are currently enrolled in the lymphedema treatment program in Leogane who 1) have been trained in the techniques of self-care, 2) who live in a 10-km radius of the hospital, and 3) for whom we have adequate data on incidence of acute bacterial infections, risk factors for infection, and ability to comply with the treatment protocol (particularly hygiene).
- \-
Exclusion
- Don't meet inclusion criteria.
- \-
Key Trial Info
Start Date :
February 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2002
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00139100
Start Date
February 1 2001
End Date
March 1 2002
Last Update
October 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Ste. Croix
Léogâne, Haiti